Key technologies and capabilities for this role
Common questions about this position
Candidates need a Bachelor's degree in Life Sciences or related field, proficiency in German and English, and minimum 3-5 years’ experience in pharmaceutical market access or sales, preferably with biosimilars or specialty care. Experience in therapy areas such as Rare Disease, Haematology, Nephrology, Immunology, Oncology, Endocrinology, Orthopaedics, or Rheumatology is preferred, along with deep knowledge of healthcare systems and contract negotiation.
This is a field-based role covering the territory of Düsseldorf, NRW, with any non-field days spent in home office.
Responsibilities include developing and executing a regional access and sales strategy, building relationships with key accounts and decision-makers, educating on biosimilar products, identifying access barriers, utilizing CRM tools, monitoring competitors, and leading local market access initiatives.
A strong candidate has proven ability to open new markets and drive access strategy, along with excellent communication, negotiation, and relationship-building skills.
This information is not specified in the job description.
Advanced analytics and clinical research services
IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.